0001209191-20-039410.txt : 20200630
0001209191-20-039410.hdr.sgml : 20200630
20200630131638
ACCESSION NUMBER: 0001209191-20-039410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200626
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WELCH DANIEL G
CENTRAL INDEX KEY: 0001206199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 201001688
MAIL ADDRESS:
STREET 1: 4611 UNIVERSITY DR
STREET 2: 4 UNIVERSITY PLACE
CITY: DURHAM
STATE: NC
ZIP: 27707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-26
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001206199
WELCH DANIEL G
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
1
0
0
0
Common Stock
2020-06-26
4
A
0
2550
0.00
A
12300
D
Stock Option (Right to Buy)
76.58
2020-06-26
4
A
0
4250
0.00
A
2030-06-26
Common Stock
4250
4250
D
Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021
The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021.
/s/ Karah Parschauer, attorney-in-fact
2020-06-30